Revisios BV
NetherlandsFDA applicant, unverified
- Devices
- 1
What Revisios BV makes
Revisios BV manufactures OsOpia, a synthetic bone void filler designed for use in orthopedic and spinal surgeries to fill bone defects and promote bone regeneration.
OsOpia is classified as a Class II medical device and is listed under the FDA’s 510(k) pathway. The company is based in the United States.
Catalogue
OsOpia Synthetic Bone Void Filler Ref K201546
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Revisios BV have in the registry?
The registry currently lists 1 device for Revisios BV. Devices recorded under merged duplicate company entries are counted once.
Which registries list Revisios BV's devices?
Among its 1 most recently registered device, Revisios BV has devices listed in FDA 510(k) (1 device).
What risk classes do Revisios BV's devices fall under?
Among its 1 most recently registered device, the classes recorded for Revisios BV's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Revisios BV in the registry?
The most recently registered devices listed for Revisios BV include OsOpia Synthetic Bone Void Filler.